Design and Preparation of Novel Nitro-Oxide-Grafted Nanospheres with Enhanced Hydrogen Bonding Interaction for O-GlcNAc Analysis
Source abstract
Abstract
As an essential modification, O-linked β-N-acetylglucosamine (O-GlcNAc) modulates the functions of many proteins. However, site-specific characterization of O-GlcNAcylated proteins remains challenging. Herein, an innovative material grafted with nitro-oxide (N→O) groups was designed for high affinity enrichment for O-GlcNAc peptides from native proteins. By testing with synthetic O-GlcNAc peptides and standard proteins, the synthesized material exhibited high affinity and selectivity. Based on the material prepared, we developed a workflow for site-specific analysis of O-GlcNAcylated proteins in complex samples. We performed O-GlcNAc proteomics with the PANC-1 cell line, a representative model for pancreatic ductal adenocarcinoma. In total 364 O-GlcNAc peptides from 267 proteins were identified from PANC-1 cells. Among them, 183 proteins were newly found to be O-GlcNAcylated in humans (with 197 O-GlcNAc sites newly reported). The materials and methods can be facilely applied for site-specific O-GlcNAc proteomics in other complex samples.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Glycosylation and Glycoproteins Research · Peptidase Inhibition and Analysis · Carbohydrate Chemistry and Synthesis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C. 20007, United States
Catalysis Center for Energy Innovation, University of Delaware, Newark, Delaware 19716, United States
Department of Chemistry, Southern University of Science and Technology, Shenzhen 518055, China
Funding
National Cancer Institute · Georgetown University · Dekelbaum Foundation
References (58)
Show source-provided references
1. 10.1016/j.cell.2006.08.01910.1016/j.cell.2006.08.019 ↗
2. 10.1093/glycob/cww08610.1093/glycob/cww086 ↗
3. 10.1016/s0021-9258(17)43295-910.1016/s0021-9258(17)43295-9 ↗
4. 10.1016/s0021-9258(19)57510-x10.1016/s0021-9258(19)57510-x ↗
5. 10.1083/jcb.20150110110.1083/jcb.201501101 ↗
6. 10.1038/nrm.2017.2210.1038/nrm.2017.22 ↗
7. 10.1074/jbc.aw119.00322610.1074/jbc.aw119.003226 ↗
8. 10.1152/physrev.00043.201910.1152/physrev.00043.2019 ↗
9. 10.1021/acs.chemrev.1c0100610.1021/acs.chemrev.1c01006 ↗
10. 10.1021/acs.chemrev.0c0088410.1021/acs.chemrev.0c00884 ↗
11. 10.1074/mcp.r120.00220610.1074/mcp.r120.002206 ↗
12. 10.1021/pr200272610.1021/pr2002726 ↗
13. 10.1016/j.mcpro.2021.10016710.1016/j.mcpro.2021.100167 ↗
14. 10.1074/mcp.o112.01836610.1074/mcp.o112.018366 ↗
15. 10.1074/mcp.m112.02663310.1074/mcp.m112.026633 ↗
16. 10.1073/pnas.161045211410.1073/pnas.1610452114 ↗
17. 10.1002/anie.20080490510.1002/anie.200804905 ↗
18. 10.1074/mcp.o115.04962710.1074/mcp.o115.049627 ↗
19. 10.1021/acs.analchem.6b0496010.1021/acs.analchem.6b04960 ↗
20. 10.1016/j.talanta.2017.03.04910.1016/j.talanta.2017.03.049 ↗
21. 10.1002/anie.20211784910.1002/anie.202117849 ↗
22. 10.1074/mcp.m900268-mcp20010.1074/mcp.m900268-mcp200 ↗
23. 10.1073/pnas.120042510910.1073/pnas.1200425109 ↗
24. 10.1002/path.492910.1002/path.4929 ↗
25. 10.1021/acs.analchem.8b0568810.1021/acs.analchem.8b05688 ↗
26. 10.1074/mcp.ra117.00026110.1074/mcp.ra117.000261 ↗
27. 10.1021/acs.analchem.0c0128410.1021/acs.analchem.0c01284 ↗
28. 10.1021/acs.analchem.1c0403110.1021/acs.analchem.1c04031 ↗
29. 10.1021/ja047872b10.1021/ja047872b ↗
30. 10.1073/pnas.163282110010.1073/pnas.1632821100 ↗
31. 10.1002/anie.20211005310.1002/anie.202110053 ↗
32. 10.1021/acschembio.8b0105210.1021/acschembio.8b01052 ↗
33. 10.1021/acschembio.1c0098110.1021/acschembio.1c00981 ↗
34. 10.1016/j.trac.2012.03.00910.1016/j.trac.2012.03.009 ↗
35. 10.1002/anie.20120109610.1002/anie.201201096 ↗
36. 10.1016/j.talanta.2016.05.03410.1016/j.talanta.2016.05.034 ↗
37. 10.1016/j.trac.2019.06.02010.1016/j.trac.2019.06.020 ↗
38. 10.1016/j.aca.2015.10.02410.1016/j.aca.2015.10.024 ↗
39. 10.1039/c4nr00274a10.1039/c4nr00274a ↗
40. 10.1016/j.chroma.2014.06.04910.1016/j.chroma.2014.06.049 ↗
41. 10.1016/j.desal.2011.05.02810.1016/j.desal.2011.05.028 ↗
42. 10.1007/s00216-022-03920-z10.1007/s00216-022-03920-z ↗
43. 10.1002/cpps.2410.1002/cpps.24 ↗
44. 10.1021/acs.analchem.6b0336510.1021/acs.analchem.6b03365 ↗
45. 10.1158/2326-6066.cir-18-026610.1158/2326-6066.cir-18-0266 ↗
46. 10.1093/nar/gkm25910.1093/nar/gkm259 ↗
47. 10.1101/gr.84900410.1101/gr.849004 ↗
48. 10.1093/bioinformatics/btx46910.1093/bioinformatics/btx469 ↗
49. 10.1038/s41467-019-09234-610.1038/s41467-019-09234-6 ↗
50. 10.21105/joss.0168610.21105/joss.01686 ↗
51. 10.1021/jacs.9b1211710.1021/jacs.9b12117 ↗
52. 10.1038/nprot.2009.2110.1038/nprot.2009.21 ↗
53. 10.1016/j.matlet.2010.12.04710.1016/j.matlet.2010.12.047 ↗
54. 10.1016/j.jnucmat.2010.08.02410.1016/j.jnucmat.2010.08.024 ↗
55. 10.1039/c2cp22341d10.1039/c2cp22341d ↗
56. 10.1038/ncb356210.1038/ncb3562 ↗
57. 10.1158/0008-5472.can-17-351210.1158/0008-5472.can-17-3512 ↗
58. 10.1093/glycob/cwab00310.1093/glycob/cwab003 ↗